RCKT · Rocket Pharmaceuticals, Inc. · Executive Compensation

$2.35 +0.11 (+4.91%)

Russell 2000 member Rebalance outlook locked

Market Cap

$245.90M

109.77M

Volume · Oct 20 1.89M Avg daily vol (3M) 1.78M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher Stevens	Chief Operating Officer	$242,308	$125,000	$1,250,000	$1,700,998	$236,250	$911	$3,555,467
Gaurav Shah	Chief Executive Officer	$671,076	—	$806,751	$1,613,377	$403,048	$15,988	$3,510,241
Martin Wilson	General Counsel and Chief Corporate Officer, Senior Vice President, Interim Principal Financial Officer	$488,279	—	$1,737,737	$892,676	$265,868	$13,320	$3,397,880

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Gaurav Shah	Chief Executive Officer	$635,880	—	$1,997,976	$4,001,997	$190,764	$14,790	$6,841,407
Kinnari Patel	Pharm.D., MBA President, Head of R&D and Chief Operating Officer	$545,040	—	$3,998,967	$2,000,999	$136,260	$14,790	$6,696,055
Aaron Ondrey	Chief Financial Officer, Principal Financial Officer	$362,662	—	$1,249,988	$1,249,983	$117,502	$9,628	$2,989,763
Jonathan Schwartz	Chief Medical and Gene Therapy Officer	$454,200	—	$582,734	$1,167,241	$145,344	$14,790	$2,364,309
Martin Wilson	General Counsel and Chief Corporate Officer, Senior VP	$452,560	—	$499,486	$1,000,489	$146,629	$14,790	$2,113,954
John Militello	Principal Accounting Officer and Former Interim Principal Financial Officer, Vice President	$341,455	—	$249,743	$500,234	$69,205	$14,951	$1,175,588

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Gaurav Shah	Chief Executive Officer	$625,000	—	$2,330,993	$4,668,994	$375,000	$13,566	$8,013,553
Kinnari Patel	Pharm.D., MBA President, Head of R&D and Chief Operating Officer	$537,125	—	$1,331,999	$2,667,993	$295,419	$13,566	$4,846,102
Jonathan Schwartz	Chief Medical and Gene Therapy Officer	$447,433	—	$832,482	$1,667,492	$196,871	$13,566	$3,157,844
John Militello	Principal Accounting Officer and Former Interim Principal Financial Officer, Vice President	$409,014	$5,000	$332,985	$666,991	$100,014	$13,566	$1,527,570

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Gaurav Shah	Chief Executive Officer	$598,333	—	$1,814,989	$3,684,991	$434,390	$20,500	$6,553,203
Kinnari Patel	Pharm.D., MBA President, Head of R&D and Chief Operating Officer	$522,750	—	$1,824,468	$1,842,489	$314,978	$12,200	$4,516,885
Mayo Pujols	Chief Technical Officer, Executive Vice President	$229,090	$150,000	$1,249,997	$1,249,994	$119,070	$151,551	$3,149,702
Raj Prabhakar	Chief Business Officer, Senior Vice President	$405,000	$193,600	$399,993	$1,799,999	—	$20,527	$2,819,120
Jonathan Schwartz	Chief Medical and Gene Therapy Officer	$434,600	—	$894,988	$1,004,996	$189,420	$8,453	$2,532,457
John Militello	Principal Accounting Officer and Interim Principal Financial Officer, Vice President	$376,788	—	$664,976	$584,988	$104,133	$20,500	$1,751,386

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Gaurav Shah	Chief Executive Officer	$590,000	—	—	$6,998,550	$318,600	$11,600	$7,918,750
Carlos Garcia-Parada	Former Chief Financial Officer and Principal Financial Officer	$410,000	$132,840	—	$5,139,400	—	$11,600	$5,693,840
Kinnari Patel	Pharm.D., MBA President and Chief Operating Officer	$510,000	—	—	$4,539,600	$196,222	$11,600	$5,257,422
Jonathan Schwartz	Chief Medical and Gene Therapy Officer	$410,000	—	—	$1,324,050	$136,530	$11,265	$1,881,845
Martin Wilson	General Counsel and Chief Compliance Officer, SVP	$37,727	$112,223	—	$1,411,000	—	—	$1,560,950

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Gaurav Shah	Chief Executive Officer	$540,000	$486,000	—	$5,821,735	—	$11,400	$6,859,135
Kinnari Patel	Pharm.D., MBA President and Chief Operating Officer	$450,000	$364,500	—	$3,254,721	—	$11,400	$4,080,621
Jonathan Schwartz	M.D., SVP and Chief Medical Officer	$395,000	$213,300	—	$1,251,033	—	$11,400	$1,870,733
Kamran Alam	Senior Vice President – Finance and Principal Financial Officer	$197,230	—	—	$427,670	—	$9,350	$634,250

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Gaurav Shah	Chief Executive Officer	$480,000	$349,140	—	$3,043,306	—	$11,200	$3,883,646
Kinnari Patel	Pharm.D., MBA President and Chief Operating Officer	$415,000	$257,715	—	$2,092,294	—	$11,200	$2,776,209
Kamran Alam	Senior Vice President – Finance and Principal Financial Officer	$54,545	$80,000	—	$1,916,912	—	—	$2,051,457
Jonathan Schwartz	M.D., SVP and Chief Medical Officer	$375,000	$155,250	—	$937,261	—	$8,165	$1,475,675

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Gaurav Shah	M.D. Chief Executive Officer	$413,735	$300,940	—	$5,651,220	—	$9,857	$6,375,752
Kinnari Patel	Pharm.D., MBA President and Chief Operating Officer	$358,864	$198,093	—	$2,423,050	—	$11,066	$2,991,073
Jonathan Schwartz	M.D., SVP and Chief Medical Officer	$359,820	$157,241	—	$830,761	—	$8,854	$1,356,675

Executive changes

Person	Role	Change	Effective	Filed
Joseph Manhede	Principal Accounting Officer	Appointed	2026-07-08	2026-06-30
John Militello	VP of Finance, Senior Controller, Treasurer and Principal Accounting Officer	Resigned	2026-07-07	2026-06-30
Pedro Granadillo	Board of Directors	Resigned	2025-09-30	2025-10-03
Dr. Peter Fong	Board	Appointed	2025-09-24	2025-09-29
Dr. Gotham Makker	Board of Directors	Resigned	2025-09-24	2025-09-29
Aaron Ondrey	Chief Financial Officer	Resigned	2025-09-05	2025-08-25
Chris Stevens	Chief Operating Officer	Appointed	—	2025-08-07
Christopher Stevens	Chief Operating Officer	Appointed	2025-07-07	2025-07-11
Sarbani Chaudhuri	Chief Commercial & Medical Affairs Officer	Appointed	2025-04-07	2025-04-07
Piratip Pratumsuwan	the Board	Appointed	2025-01-27	2025-01-28
Naveen Yalamanchi	Board of Directors	Resigned	2025-01-25	2025-01-28
Mark White	General Manager, Commercial Affairs	Resigned	2025-01-01	2024-12-05
Dr. Mikael Dolsten, M.D., Ph.D.	Director	Appointed	2024-09-09	2024-09-11
Aaron Ondrey	Chief Financial Officer and Principal Financial Officer	Appointed	2024-03-25	2024-03-29
R. Keith Woods	Board	Appointed	2023-12-07	2023-12-13
Mark White	Chief Medical Officer	Appointed	2023-04-04	2023-04-04

Leadership

Gaurav Shah CEO, Board Member
Aaron Ondrey CFO
Carlos Garcia-Parada CFO
John Militello CFO
Chris Stevens COO
Christopher Stevens COO
Martin Wilson General Counsel
Joseph Manhede Chief Accounting Officer
Carsten Boess Board Member
David P. Southwell Board Member
Dr. Mikael Dolsten, M.D., Ph.D. Board Member
Dr. Peter Fong Board Member
Elisabeth Björk, M.D., Ph.D. Board Member
Fady Malik Board Member
Fady Malik, M.D., Ph.D. Board Member
Mikael Dolsten Board Member
Peter Fong Board Member
Roderick Wong Board Member

Key facts CIK 1281895 CUSIP 77313F106 13F (30d) 11 filings 11 filers Visit website Investor relations